A PATIENT’S JOURNEY TO CARE
Outcomes
KDIGO guidelines recommend preemptive living donor kidney transplant as the preferred treatment choice for transplant-eligible chronic kidney disease (CKD) patients.6
Sanofi Supports
Sanofi has created an educational slide presentation on the advancements in living donation kidney transplant, including content on living donor evaluation, education, and risk assessment.
To learn more about Sanofi’s living donor presentation, “Enhancing Evaluation of Living Kidney Donors: Road to Improving Donor Education and Risk Assessment,” please see available resources at the end of this journey.
